SAMANTHA ARNOLD: Open Payments
NPI 1497436406 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,910 in 108 payments from 20 companies in 2025. Trend: 2023 $741 · 2024 $1,672 · 2025 $2,910
Food & beverage: $2,910
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $559 |
| AstraZeneca Pharmaceuticals LP | 13 | $372 |
| GENZYME CORPORATION | 10 | $357 |
| Amgen Inc. | 9 | $301 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $232 |
| LEO Pharma Inc. | 13 | $215 |
| Organon LLC | 1 | $150 |
| Grifols USA, LLC | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, NEFFY, ADBRY, VTAMA, TRELEGY ELLIPTA, Xembify.
Industry payments across CA — which companies pay providers there.
